Modified Autologous Leukocyte Cells for the Treatment of Acute Kidney Injury After Cardiac Surgery

NCT07052513 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Kidney Injury

Interventions

DRUG: Placebo
DRUG: M2RLAB 001

Sponsor

M2RLAB SL